Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novar Capital is an independent private equity firm based in London that specializes in mid-market investments across various sectors, including healthcare and life sciences. The firm focuses on acquiring and developing businesses with strong growth potential, often targeting companies in the medical technology, healthcare services, and specialized industrial sectors. Novar Capital typically partners with management teams to drive operational improvements and strategic expansion. While not a drug development company itself, it plays a significant role in the healthcare ecosystem by providing capital and strategic oversight to its portfolio companies. The firm's investment strategy emphasizes long-term value creation through a hands-on approach to business development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novar Capital.